Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03029819
Other study ID # K23AT008442
Secondary ID K23AT008442
Status Completed
Phase N/A
First received
Last updated
Start date January 18, 2017
Est. completion date October 3, 2017

Study information

Verified date December 2018
Source Georgia State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate text messaging as a way to enhance mindfulness-based treatment for smoking cessation.


Description:

This study is a pilot investigation of mindfulness-based smoking cessation treatment incorporating between-session text messaging ("iQuit Mindfully"). Participants will be randomly assigned to one of two groups: Mindfulness-based Addiction Treatment (MBAT) or iQuit Mindfully (MBAT with the addition of between-session text messages).

All participants will receive in-person group treatment based on the 8-week MBAT protocol in addition to nicotine patch therapy and self-help materials. Participants assigned to iQuit Mindfully will receive additional support via text messaging. Assessments will occur at baseline, at each of the weekly in-person visits, at end of treatment, and at 1-month follow-up. Feasibility, smoking abstinence, mindfulness practice, and indicators of tobacco dependence and psychological well-being will be assessed.


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date October 3, 2017
Est. primary completion date August 10, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- age 18-65 years

- current smoker with history of >5 cigarettes/day for past year (and expired carbon monoxide >6 parts per million [ppm])

- motivated to quit within next 30 days

- valid home address in the greater Atlanta, Georgia area

- functioning telephone number

- own a mobile phone with text messaging capacity

- can speak, read, and write in English

- at least a sixth-grade level of health literacy

Exclusion Criteria:

- contraindication for nicotine patch

- active substance abuse/dependence

- regular use of tobacco products other than cigarettes

- current use of tobacco cessation medications

- pregnancy or lactation

- household member enrolled in the study

- current diagnosis of schizophrenia or bipolar disorder, or use of antipsychotic medications

- clinically significant depressive symptoms

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness-based Addiction Treatment
Mindfulness-based Addiction Treatment (MBAT) consists of 8 weekly 2-hour sessions that teach mindfulness and cognitive-behavioral strategies for smoking cessation (Wetter et al., 2009).
iQuit Mindfully
iQuit Mindfully involves text messages on each day between treatment sessions. The text messages provide mindfulness and cognitive-behavioral strategies and support for smoking cessation.
Self-Help guide
Self-help materials for smoking cessation are based on the Treating Tobacco Use and Dependence Clinical Practice Guideline (Fiore et al. Clinical practice guideline for treating tobacco use and dependence, 2008).
Drug:
Nicotine Patch
Patch therapy (beginning the week before quit day) for participants who smoke >10 cigarettes/day will consist of 4 weeks of 21 mg patches, 1 week of 14 mg patches, and 1 week of 7 mg patches. Patch therapy for participants who smoke 5-10 cigarettes/day will consist of 4 weeks of 14 mg patches and 2 weeks of 7 mg patches.

Locations

Country Name City State
United States Georgia State University Atlanta Georgia

Sponsors (6)

Lead Sponsor Collaborator
Georgia State University George Washington University, National Center for Complementary and Integrative Health (NCCIH), The Catholic University of America, University of Chicago, University of Utah

Country where clinical trial is conducted

United States, 

References & Publications (2)

Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008 Aug;35(2):158-76. doi: 10.1016/j.amepre.2008.04.009. Review. — View Citation

Wetter, D. W., Vidrine, J. I., Fine, M., Rowan, P. J., Reitzel, L. R., & Tindle, H. (2009). Mindfulness- Based Addiction Treatment (MBAT) Manual.

Outcome

Type Measure Description Time frame Safety issue
Other Number of Cigarettes Smoked Per Day Self-reported number of cigarettes smoked per day (questionnaire) End of treatment (8 weeks)
Other Weekly Mindfulness Practice Self-reported average weekly mindfulness practice (questionnaire) Throughout treatment period (8 weeks)
Other Self-reported Mindfulness and Psychological Functioning Mindfulness, affect, self-efficacy, dependence, and withdrawal symptoms (questionnaire) End of treatment (8 weeks)
Primary Smoking Abstinence Number of participants who abstained from smoking (based on self-reported 7-day abstinence, which is biochemically verified by expired carbon monoxide <6 parts per million (ppm) End of Treatment (8 weeks)
Secondary Participant Engagement Number of participants who respond to interactive text messages Over the 8-week treatment period
Secondary Participant Ratings Perceived Text Message Helpfulness (minimum value 1 ["not at all helpful"], maximum value 10 ["extremely helpful"], higher scores mean better outcome) End of Treatment (8 weeks)
Secondary Attrition Number of participants who do not attend end-of-treatment session End of treatment (8 weeks)
See also
  Status Clinical Trial Phase
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Active, not recruiting NCT02643914 - Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings N/A
Recruiting NCT02422914 - Benefits of Tobacco Free Cigarette N/A
Active, not recruiting NCT02629679 - Sports, Education and Consumption of Substances in Adolescents N/A
Completed NCT02218281 - Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation N/A
Completed NCT02385227 - Characterization of Biomarkers of Tobacco Exposure, Urge-to-Smoke Following Exclusive and Dual Ad Lib Use of Electronic Cigarettes N/A
Completed NCT01199380 - Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms Phase 2
Completed NCT00802919 - Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors Phase 4
Completed NCT00756704 - The Effectiveness of Smoking Cessation Guidelines in the Emergency Department N/A
Completed NCT01081119 - Brief Voluntary Alcohol and Drug Intervention for Middle School Youth Phase 2
Completed NCT01692353 - Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers N/A
Completed NCT00682474 - School Nurse-Delivered Smoking Cessation Intervention Phase 2/Phase 3
Completed NCT05520775 - Semaglutide for Alcohol Use Disorder Phase 2
Completed NCT03743532 - E-Cigarettes and Financial Incentives to Promote Tobacco Harm Reduction Among Adults Accessing Shelter Services N/A
Terminated NCT03840694 - Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world Behavior N/A
Completed NCT06032793 - Effects of Deep Breathing Exercise on Pulmonary Function, Perceived Stress and Physical Fitness. N/A
Terminated NCT03326128 - High Dose Bupropion for Smoking Cessation - Pilot Study Phase 2
Recruiting NCT03218670 - Your Health in On Click N/A
Completed NCT02538042 - Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue) N/A